Clinical Trial Update: Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and efficacy of BBI-2000 for treating and preventing contact dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contact Dermatitis

Drugs mentioned

• BBI-2000

Snippet

Sponsor: Fresh Tracks Therapeutics, Inc. | Conditions: Contact Dermatitis | Phase 1 | Status: COMPLETED